Warp Sciences
South San Francisco, United States
Physical AI & World Models · Founded 2026 · Series A
Warp Sciences is a U.S. chemistry contract research organisation that combines expert chemists, AI and robotics to make and test the molecules drug discovery teams need. Its labs are designed for automation from the outset, so each experiment feeds data back into better models and more capable workflows. The company serves biotech and pharmaceutical customers, focusing on lead optimisation and analog synthesis. It works with a small number of design partners and holds no proprietary drug pipeline of its own. Founded by Kevin Weil, DJ Patil, Solomon Reisberg and Manohar Paluri, Warp emerged from stealth in October 2026 with a $215 million Series A led by Lightspeed Venture Partners, valuing it at $865 million.
Visit website- Based in
- South San Francisco, United States
- Founded
- 2026
- Builds
- Physical AI & World Models, Robotics Data, Robotics Development Software & Tools
- Industries
- Healthcare
- Stage
- Series A
- Team
- 11 to 50 people
- Funding raised
- $215M
- Open roles
- 9